197 related articles for article (PubMed ID: 29260607)
1. Tofacitinib rapidly ameliorated polyarthropathy in a patient with systemic sclerosis.
Komai T; Shoda H; Hanata N; Fujio K
Scand J Rheumatol; 2018 Nov; 47(6):505-506. PubMed ID: 29260607
[No Abstract] [Full Text] [Related]
2. Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre.
You H; Zhang G; Wang Q; Zhang S; Zhao J; Tian X; Li H; Li M; Zeng X
Ann Rheum Dis; 2019 Oct; 78(10):1441-1443. PubMed ID: 31005902
[No Abstract] [Full Text] [Related]
3. The use of JAK inhibitors in the treatment of progressive systemic sclerosis.
Deverapalli SC; Rosmarin D
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e328. PubMed ID: 29444362
[No Abstract] [Full Text] [Related]
4. Tofacitinib for psoriatic arthritis (PsA) is now approved by the European Commission.
Rheumatology (Oxford); 2018 Sep; 57(9):e55. PubMed ID: 30137541
[No Abstract] [Full Text] [Related]
5. [Tofacitinib].
Döker S; Dewenter M; El-Armouche A
Dtsch Med Wochenschr; 2014 May; 139(19):1003-8. PubMed ID: 24782154
[TBL] [Abstract][Full Text] [Related]
6. Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report.
Haynes D; Topham C; Hagstrom E; Greiling T
Australas J Dermatol; 2020 Feb; 61(1):e108-e110. PubMed ID: 31318041
[No Abstract] [Full Text] [Related]
7. Tofacitinib in psoriatic arthritis.
Wang TS; Tsai TF
Immunotherapy; 2017 Nov; 9(14):1153-1163. PubMed ID: 28967798
[TBL] [Abstract][Full Text] [Related]
8. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
Mrowietz U; Gerdes S; Gläser R; Schröder O
Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
[No Abstract] [Full Text] [Related]
9. XELJANZ (Tofacitinib) for Chronic Plaque Psoriasis.
Gupta AK; Daigle D; Abramovits W; Vincent KD
Skinmed; 2015; 13(3):227-9. PubMed ID: 26380510
[No Abstract] [Full Text] [Related]
10. Topical tofacitinib in treatment of alopecia areata.
Ferreira SB; Ferreira RB; Scheinberg MA
Einstein (Sao Paulo); 2020; 18():eAI5452. PubMed ID: 32785452
[No Abstract] [Full Text] [Related]
11. Alopecia universalis. Partial response to tofacitinib.
Ruiz-Villaverde R; Cuenca-Barrales C; Linares-Gonzalez L; Ródenas-Herranz T
Med Clin (Barc); 2019 Aug; 153(3):e15. PubMed ID: 30718001
[No Abstract] [Full Text] [Related]
12. Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model.
Vidal B; Cascão R; Finnilä MAJ; Lopes IP; da Glória VG; Saarakkala S; Zioupos P; Canhão H; Fonseca JE
Rheumatology (Oxford); 2018 Aug; 57(8):1461-1471. PubMed ID: 28968875
[TBL] [Abstract][Full Text] [Related]
13. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.
Kim SR; Heaton H; Liu LY; King BA
JAMA Dermatol; 2018 Mar; 154(3):370-371. PubMed ID: 29387870
[No Abstract] [Full Text] [Related]
14. A pilot study of tofacitinib for refractory Behçet's syndrome.
Liu J; Hou Y; Sun L; Li C; Li L; Zhao Y; Zeng X; Zhang F; Zheng W
Ann Rheum Dis; 2020 Nov; 79(11):1517-1520. PubMed ID: 32461206
[No Abstract] [Full Text] [Related]
15. Tofacitinib therapy for children with severe alopecia areata.
Dai YX; Chen CC
J Am Acad Dermatol; 2019 Apr; 80(4):1164-1166. PubMed ID: 30630026
[No Abstract] [Full Text] [Related]
16. Tofacitinib for familial Mediterranean fever: a new alternative therapy?
Garcia-Robledo JE; Aragón CC; Nieto-Aristizabal I; Posso-Osorio I; Cañas CA; Tobón GJ
Rheumatology (Oxford); 2019 Mar; 58(3):553-554. PubMed ID: 30535114
[No Abstract] [Full Text] [Related]
17. Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients.
Liu LY; Craiglow BG; King BA
J Am Acad Dermatol; 2018 Feb; 78(2):403-404.e1. PubMed ID: 29108908
[No Abstract] [Full Text] [Related]
18. Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis.
Gupta AK; Cernea M; Lynde CW
Skin Therapy Lett; 2017 Mar; 22(2):1-7. PubMed ID: 28329404
[TBL] [Abstract][Full Text] [Related]
19. Tofacitinib for treatment of rheumatoid arthritis.
Rakieh C; Conaghan PG
Adv Ther; 2013 Aug; 30(8):713-26. PubMed ID: 23943546
[TBL] [Abstract][Full Text] [Related]
20. Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis.
Dhayalan A; King BA
JAMA Dermatol; 2016 Apr; 152(4):492-3. PubMed ID: 26630079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
